Suitable antibacterial substances for the treatment of urinary tract infections

Anti-Infective Agents in Medicinal Chemistry

Volumn 5, Issue 3, 2006, Pages 309-329

  Wagenlehner, Floian M E ^a   Naber, Kurt G ^a  

^a Urologische Klinik   (Germany)

Author keywords

Antibiotic resistance; Chemistry of antibacterial substances; Pharmacodynamics; Pharmacokinetics; Urinary tract infections; Uropathogens

Indexed keywords

ACETYLCYSTEINE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; FOSFOMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; NEW DRUG; NORFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; CHEMISTRY; CLINICAL TRIAL; CYSTITIS; DRUG DESIGN; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; META ANALYSIS; NONHUMAN; OUTPATIENT CARE; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACOLOGICAL PARAMETERS; PYELONEPHRITIS; QUANTITATIVE ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW; TREATMENT INDICATION; URINARY TRACT INFECTION;

EID: 33745817837     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152106777697853     Document Type: Review

References (123)

1. Foxman, B. Am. J. Med., 2002, 113. Suppl 1A, 5S-13S.
2. Warren, J. W.; Abrutyn, E.; Hebel, J. R.; Johnson, J. R.; Schaeffer, A. J.; Stamm, W. E. Clin. Infect. Dis., 1999, 29, 745-58.
3. Gales, A. C.; Jones, R. N.; Gordon, K. A.; Sader, H. S.; Wilke, W. W.; Beach, M. L.; Pfaller, M. A.; Doern, G. V. J. Antimicrob. Chemother., 2000, 45, 295-303.
4. Ruden, H.; Gastmeier, P.; Daschner, F. D.; Schumacher, M. Infection, 1997, 25, 199-202.
5. Maki, D. G.; Tambyah, P. A. Emerg. Infect. Dis., 2001, 7, 342-7.
6. Patton, J. P.; Nash, D. B.; Abrutyn, E. Med. Clin. North. Am., 1991, 75, 495-513.
7. Wagenlehner, F. M.; Krcmery, S.; Held, C.; Klare, I.; Witte, W.; Bauernfeind, A.; Schneider, I.; Naber, K. G. Int. J. Antimicrob. Agents, 2002, 583-91.
8. Wagenlehner, F. M.; Naber, K. G. Curr. Opin. Urol., 2001, 11, 49-53.
9. Wagenlehner, F. M.; Weidner, W.; Naber, K. G. J. Hosp. Infect., 2005, 60, 191-200.
10. Mulvey, M. A.; Schilling, J. D.; Martinez, J. J.; Hultgren, S. J. Proc. Natl. Acad. Sci. USA, 2000, 97, 8829-35.
11. Martinez, J. J.; Mulvey, M. A.; Schilling, J. D.; Pinkner, J. S.; Hultgren, S. J. EMBO J, 2000, 19, 2803-12.
12. Wullt, B.; Bergsten, G.; Samuelsson, M.; Svanborg, C. Urologe. A, 2003, 42, 233-7.
13. Svanborg, C.; Hedlund, M.; Connell, H.; Agace, W.; Duan, R. D.; Nilsson, A.; Wullt, B. Ann. N. Y. Acad. Sci., 1996, 797, 177-90.
14. Samuelsson, P.; Hang, L.; Wullt, B.; Irjala, H.; Svanborg, C. Infect. Immun., 2004, 72, 3179-86.
15. Schilling, J. D.; Martin, S. M.; Hunstad, D. A.; Patel, K. P.; Mulvey, M. A.; Justice, S. S.; Lorenz, R. G.; Hultgren, S. J. Infect. Immun., 2003, 71, 1470-80.
16. Schilling, J. D.; Martin, S. M.; Hung, C. S.; Lorenz, R. G.; Hultgren, S. J. Proc. Natl. Acad. Sci. USA, 2003, 100, 4203-8.
17. Geerlings, S. E.; Stolk, R. P.; Camps, M. J.; Netten, P. M.; Hoekstra, J. B.; Bouter, K. P.; Bravenboer, B.; Collet, J. T.; Jansz, A. R.; Hoepelman, A. I. Diab. Care, 2000, 23, 744-9.
18. Meiland, R.; Geerlings, S. E.; Hoepelman, A. I. Drugs, 2002, 62, 1859-68.
19. Anderson, G. G.; Palermo, J. J.; Schilling, J. D.; Roth, R.; Heuser, J.; Hultgren, S. J. Science, 2003, 301, 105-7.
20. Anderson, G. G.; Dodson, K. W.; Hooton, T. M.; Hultgren, S. J. Trends Microbiol., 2004, 12, 424-30.
21. Schaeffer, A. J.; Jones, J. M.; Dunn, J. K. N. Engl. J. Med., 1981, 304, 1062-6.
22. George, N. In The. scientific. basis. of. urology, Fitzpatrick JM Mundy AR, Neal DE, George NJR, ed.; ISIS medical media: Oxford, UK, 1999; Vol. 1, pp. 143-173.
23. Goto, T.; Nakame, Y.; Nishida, M.; Ohi, Y. Int. J. Antimicrob. Agents, 1999, 11, 227-31; discussion 237-9.
24. Reid, G. Int. J. Antimicrob. Agents, 1999, 11, 223-6; discussion 237-9.
25. Nickel, J. C.; Olson, M. E.; Costerton, J. W. Infection, 1991, 19. Suppl. 3, S126-30.
26. Costerton, J. W. Int. J. Antimicrob. Agents, 1999, 11, 217-21; discussion 237-9.
27. Marchese, A.; Bozzolasco, M.; Gualco, L.; Debbia, E. A.; Schito, G. C.; Schito, A. M. Int. J. Antimicrob. Agents, 2003, 22. Suppl. 2, 95-100.
28. Gupta, K.; Hooton, T. M.; Stamm, W. E. Ann. Intern. Med., 2001, 135, 41-50.
29. Hooton, T. M. Infect. Dis. Clin. North Am., 2003, 17, 303-32.
30. Kahlmeter, G. J. Antimicrob. Chemother., 2003, 51, 69-76.
31. Talan, D. A.; Stamm, W. E.; Hooton, T. M.; Moran, G. J.; Burke, T.; Iravani, A.; Reuning-Scherer, J.; Church, D. A. JAMA, 2000, 283, 1583-90.
32. Jones, R. N.; Kugler, K. C.; Pfaller, M. A.; Winokur, P. L. Diagn. Microbiol. Infect. Dis., 1999, 35, 55-63.
33. Gordon, K. A.; Jones, R. N. Diagn. Microbiol. Infect. Dis., 2003, 45, 295-301.
34. Mathai, D.; Jones, R. N.; Pfaller, M. A. Diagn. Microbiol. Infect. Dis., 2001, 40, 129-36.
35. Bouza, E.; San Juan, R.; Munoz, P.; Voss, A.; Kluytmans, J. Clin. Microbiol. Infect., 2001, 7, 523-31.
36. Wagenlehner, F. M.; Niemetz, A.; Dalhoff A.; Naber, K. G. Int. J. Antimicrob. Agents, 2002, 19, 557-64.
37. Bjerklund Johansen, T. ESIU-board members: Pan-european-prevalence study on nosocomially acquired UTI (NAUTI). http://www.uroweb.org/ index.php?structure_id=224
38. Karlowsky, J. A.; Kelly, L. J.; Thornsberry, C.; Jones, M. E.; Evangelista, A. T.; Critchley, I. A.; Sahm, D. F. Int. J. Antimicrob. Agents, 2002, 19, 21-31.
39. Karlowsky, J. A.; Kelly, L. J.; Thornsberry, C.; Jones, M. E.; Sahm, D. F. Antimicrob. Agents Chemother., 2002, 46, 2540-5.
40. Morrissey, I.; Farrell, D.J.; Robbins, M.; Werling, H.-O.; Felingham, D. Clin. Microbiol. Infect., 2003, 9. (Suppl 1).
41. Luna, C. M.; Vujacich, P.; Niederman, M. S.; Vay, C.; Gherardi, C.; Matera, J.; Jolly, E. C. Chest, 1997, 111, 676-85.
42. Montravers, P.; Gauzit, R.; Muller, C.; Marmuse, J. P.; Fichelle, A.; Desmonts, J. M. Clin. Infect. Dis., 1996, 23, 486-94.
43. Elhanan, G.; Sarhat, M.; Raz, R. J. Infect, 1997, 35, 283-8.
44. Abraham, E., Chain, E. Nature, 1940, 146, 837.
45. Naber, K. G. Int. J. Antimicrob. Agents, 2001, 17, 331-41.
46. Frimodt-Moller, N. Int. J. Antimicrob. Agents, 2002, 19, 333-9.
47. Frimodt-Moller, N. Int. J. Antimicrob. Agents, 2002, 19, 546-53.
48. Scheld, W. M. Emerg. Infect. Dis., 2003, 9, 1-9.
49. Wagenlehner, F. M.; Wydra, S.; Onda, H.; Kinzig-Schippers, M.; Sorgel, F.; Naber, K. G. Antimicrob. Agents Chemother., 2003, 47, 3789-94.
50. Boy, D.; Well, M.; Kinzig-Schippers, M.; Sorgel, F.; Ankel-Fuchs, D.; Naber, K. G. Int. J. Antimicrob. Agents, 2004, 23. Suppl. 1, S6-16.
51. Simon, C., Stille, W. Antibiotika-Therapie in Klinik und Praxis, Schattauer: Stuttgart, New York 2000.
52. Lancini, G., Parenti F. Antibiotics, an integrated view, Springer-Verlag: New York, Heidelberg, Berlin 1982.
53. Molavi, A. American family physician, 1991, March 1991.
54. Braveny, I., Maschmeyer, G. Infektionskrankheiten: Diagnostik-Klinik-Therapie, medco Verlag GmbH: München 2002.
55. Bergogne-Berezin, E. Presse. Med., 1988, 17, 1878-1882.
56. Laws, A.; Page, M. J. Chemother., 1996, 8. Suppl 2, 7-22.
57. Shah, P. M.; Isaacs, R. D. J. Antimicrob. Chemother., 2003, 52, 538-42.
58. Hammond, M. L. J. Antimicrob. Chemother., 2004, 53. Suppl. 2, ii7-9.
59. Trautmann, M., Lepper, P, Bodmann, KF. Arzneimitteltherapie, 2006, 2, 50-56.
60. Naber, K. G.; Adam, D. Int. J. Antimicrob. Agents, 1998, 10, 255-7.
61. Van Bambeke, F.; Michot, J. M.; Van Eldere, J.; Tulkens, P. M. Clin. Microbiol. Infect., 2005, 11, 256-80.
62. Sorge, F.; Kinzig, M. Am. J. Med., 1993, 94, 56S-69S.
63. Benveniste, R.; Davies, J. Antimicrob. Agents Chemother., 1973, 4, 402-9.
64. Mingeot-Leclercq, M. P.; Glupczynski, Y.; Tulkens, P. M. Antimicrob. Agents Chemother., 1999, 43, 727-37.
65. Mingeot-Leclercq, M. P.; Tulkens, P. M. Antimicrob. Agents Chemother., 1999, 43, 1003-12.
66. Goettsch, W. G.; Janknegt, R.; Herings, R. M. Br. J. Clin. Pharmacol., 2004, 58, 184-9.
67. Minassian, M. A.; Lewis, D. A.; Chattopadhyay, D.; Bovill, B.; Duckworth, G. J.; Williams, J. D. Int. J. Antimicrob. Agents, 1998, 10, 39-47.
68. Raz, R.; Chazan, B.; Kennes, Y.; Colodner, R.; Rottensterich, E.; Dan, M.; Lavi, I.; Stamm, W. Clin. Infect. Dis., 2002, 34, 1165-9.
69. Miller, L. G.; Tang, A. W. Mayo. Clin. Proc., 2004, 79, 1048-53; quiz 1053-4.
70. Petersen, E. E.; Wingen, F.; Fairchild, K. L.; Halfhide, A.; Hendrischk, A.; Links, M.; Schad, M.; Scholz, H. R.; Schurmann, N.; Siegmann, S. et al. J. Antimicrob. Chemother., 1990, 26 Suppl. B, 147-52.
71. Jardin, A.; Cesana, M. Antimicrob. Agents Chemother., 1995, 39, 215-20.
72. Del Rio, G.; Dalet, F.; Aguilar, L.; Caffaratti, J.; Dal-Re, R. Antimicrob. Agents Chemother., 1996, 40, 408-12.
73. Richard, G.D.C.; Ruoff, G.; Corrado, M.; Fowler, C. In 6th. Int. Symp. New Quinolones: Denver, Colorado, USA, Nov 15-17, 1998.
74. Henry, D.C. Jr.; Bettis, R. B.; Riffer, E.; Haverstock, D. C.; Kowalsky, S. F.; Manning, K.; Hamed, K. A.; Church, D. A. Clin. Ther., 2002, 24, 2088-104.
75. Schaeffer, A. J. Dis. Mon., 2003, 49, 129-47.
76. Hooton, T. M. Int. J. Antimicrob. Agents, 2003, 12. Suppl. 2, 65-72.
77. Zhanel, G.G.; Hisanaga, T.L.; Laing, N.M.; DeCorby, M.R.; Nichol, K.A.; Palatnik, L.P.; Johnson, J.; Noreddin, A.; Harding, G.K.; Nicolle, L.E.; Hoban, D.J. NAUTICA Group. Int. J. Antimicrob. Agents, 2005, 26(5), 380-8.
78. Pitkajarvi, T.; Pyykonen, M. L.; Kannisto, K.; Piippo, T.; Viita, P. Arzneimittelforschung, 1990, 40, 1156-8.
79. Nicolle, L. E. J. Antimicrob. Chemother., 2000, 46. Suppl. 1, 35-9; discussion 63-5.
80. Nicolle, L. E.; Madsen, K. S.; Debeeck, G. O.; Blochlinger, E.; Borrild, N.; Bru, J. P.; McKinnon, C.; O'Doherty, B.; Spiegel, W.; Van Balen, F. A.; Menday, P. Scand. J. Infect. Dis., 2002, 34, 487-92.
81. Menday, A. P. Int. J. Antimicrob. Agents, 2002, 20, 297-300.
82. Kahlmeter, G. Int. J. Antimicrob. Agents, 2003, 22 Suppl. 2, 49-52.
83. Kahlmeter, G.; Menday, P. J. Antimicrob. Chemother., 2003, 52, 128-31.
84. Naber, K. G.; Koch, E. M. Infection, 1993, 21, 34-9.
85. Hooton, T. M.; Winter, C.; Tiu, F.; Stamm, W. E. JAMA, 1995, 273, 41-5.
86. Kavatha, D.; Giamarellou, H.; Alexiou, Z.; Vlachogiannis, N.; Pentea, S.; Gozadinos, T.; Poulakou, G.; Hatzipapas, A.; Koratzanis, G. Antimicrob. Agents Chemother., 2003, 47, 897-900.
87. Hooton, T. M.; Scholes, D.; Gupta, K.; Stapleton, A. E.; Roberts, P. L.; Stamm, W. E. JAMA, 2005, 293, 949-55.
88. Lecomte, F., Allaert, FA. Medecine et Maladies Infectieuses, 1996, 26, 338-343.
89. Schito, G. C. Int. J. Antimicrob. Agents, 2003, 22, Suppl. 2, 79-83.
90. Ungheri, D.; Albini, E.; Belluco, G. J. Chemother., 2002, 14, 237-40.
91. Stein, G. E. Clin. Ther., 1999, 21, 1864-72.
92. Guay, D. R. Drugs, 2001, 61, 353-64.
93. Brumfitt, W.; Hamilton-Miller, J. M. J. Antimicrob. Chemother., 1998, 42, 363-71.
94. Karpman, E.; Kurzrock, E. A. J. Urol, 2004, 172, 448-53.
95. Kass, E. H. J. Urol, 2002, 167, 1016-9; discussion 1019-21.
96. Gleckman, R.; Bradley, P.; Roth, R.; Hibert, D.; Pelletier, C. J. Urol., 1985, 133, 176-8.
97. Jernelius, H.; Zbornik, J.; Bauer, C. A. Acta Med. Scand., 1988, 223, 469-77.
98. Ode, B.; Broms, M.; Walder, M.; Cronberg, S. Acta Med. Scand., 1980, 207, 305-7.
99. Stamm, W. E.; McKevitt, M.; Counts, G. W. Ann. Intern. Med., 1987, 106, 341-5.
100. Talan, D. A.; Klimberg, I. W.; Nicolle, L. E.; Song, J.; Kowalsky, S. F.; Church, D. A. J. Urol., 2004, 171, 734-9.
101. Naber, K. G.; Bartnicki, A.; Bischoff, W.; Hanus, M.; Milutinovic, S.; van Belle, F.; Schonwald, S.; Weitz, P.; Ankel-Fuchs, D. Int. J. Antimicrob. Agents, 2004, 23. Suppl. 1, S41-53.
102. Richard, G. A.; Klimberg, I. N.; Fowler, C. L.; Callery-D'Amico, S.; Kim, S. S. Urology, 1998, 52, 51-5.
103. Naber. K.G.S.S.; Hauke, W. Chemotherapie J., 2001, 10, 29-34.
104. Vogel, F.; Naber, K.G.; Wacha, H.; Shah, P.; Sörgel, F.; Kayser, F.H.; Maschmeyer, G.; Lode, H. Chemotherapie J., 1999, 8, 2-49.
105. Naber, K.; Fünfstück, R.; Gatermann, S.; Hoyme, U. Chemotherapie J., 2004, 13, 78-84.
106. Wagenlehner, F.; Naber, K.G. European Urology (update series), 2004, 2, 125-135.
107. Cheng, Q.; Nelson, D.; Zhu, S.; Fischetti, V. A. Antimicrob. Agents Chemother., 2005, 49, 111-7.
108. Yoong, P.; Schoch, R.; Nelson, D.; Fischetti, V. A. J. Bacteriol., 2004, 186, 4808-12.
109. Snydman, D. R.; Jacobus, N. V.; McDermott, L. A.; Lonks, J. R.; Boyce, J. M. Antimicrob. Agents Chemother., 2000, 44, 3447-50.
110. Laganas, V.; Alder, J.; Silverman, J. A. Antimicrob. Agents Chemother., 2003, 47, 2682-4.
111. Fuchs, P. C.; Barry, A. L.; Brown, S. D. J. Antimicrob. Chemother., 2002, 49, 467-70.
112. Louie, A.; Kaw, P.; Liu, W.; Jumbe, N.; Miller, M. H.; Drusano, G. L. Antimicrob. Agents Chemother., 2001, 45, 845-51.
113. Rubinstein, E.; Vaughan, D. Drugs, 2005, 65, 1317-36.
114. Kumamoto, Y.; Tsukamoto, T.; Matsukawa, M.; Kunishima, Y.; Hirose, T.; Yamaguti, O.; Ishibashi, K.; Shigeta, S.; Suzutani, T.; Yoshida, H.; Imafuku, Y.; Murai, M.; Watanabe, K.; Kobayashi, Y.; Uchida, H.; Matsuda, S.; Sato, S.; Fujime, M.; Fujita, K.; Igari, J.; Oguri, T.; Yamaguchi, K.; Furuya, N.; Deguchi, T.; Ishihara, S.; Ooe, H.; Nishikawa, M.; Oka, T.; Kitamura, M.; Fukuhara, Y.; Kamidono, S.; Arakawa, S.; Kumon, H.; Monden, K.; Matsumoto, T.; Takahashi, K.; Naito, S.; Egashira, T.; Kohno, S.; Miyazaki, Y.; Hirakata, Y.; Aoki, S. Jpn. J. Antibiot., 2004, 57, 246-74.
115. Heinzl, S. Chemotherapie J., 2005, 14, 54-57.
116. Jones, R. N.; Sader, H. S.; Fritsche, T. R. Diagn. Microbiol. Infect. Dis., 2005, 52, 71-4.
117. Talan, D. A.; Naber, K. G.; Palou, J.; Elkharrat, D. Int. J. Antimicrob. Agents, 2004, 23. Suppl. 1, S54-66.
118. Theil, F.P.F.M.; Stass, H. Clin. Microbiol. Infect, 2003, 9. (Suppl. 1), Abstract 1228.
119. Rubinstein, E. Chemotherapy, 2001, 47 Suppl. 3, 3-8; discussion 44-8.
120. Dalhoff, A.; Schmitz, F. J. Eur. J. Clin. Microbiol. Infect. Dis., 2003, 22, 203-21.
121. Eschenburg, S.; Priestman, M. A.; Abdul-Latif, F. A.; Delachaume, C.; Fassy, F.; Schonbrunn, E. J. Biol. Chem., 2005, 280, 14070-5.
122. Kaatz, G. W. Expert. Opin. Emerg. Drugs, 2002, 7, 223-33.
123. Heinisch, L.; Wittmann, S.; Stoiber, T.; Scherlitz-Hofmann, I.; Ankel-Fuchs, D.; Mollmann, U. Arzneimittelforschung, 2003, 53, 188-95.